Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)
在一项前瞻性、双盲、随机、两周期交叉、多中心研究中，米拉贝隆和托特罗定治疗膀胱过度活动症患者的患者报告结果（PREFER）
期刊:Health and Quality of Life Outcomes
影响因子:3.4
doi:10.1186/s12955-018-0892-0
Herschorn, Sender; Staskin, David; Tu, Le Mai; Fialkov, Jonathan; Walsh, Terry; Gooch, Katherine; Schermer, Carol R
